NYSE:ABT

Abbott Laboratories Stock Insider Trading

Healthcare > Medical - Devices

Buy ABT

*Your capital is at risk

$105.70

+0.0750 (+0.0710%)

At Close: Jul 31, 2026

Abbott Laboratories Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.32. In total, the insiders bought 1.74M and sold 79.17K ABT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	90.32
● Buy	1.74M shares
● Sell	79.17K shares
78% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Feb 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 90.32. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 24, 2026 Buy	Common shares without par value A-Award	Ahuja Nita Director	Director	2 286 Value: $208.4K
Apr 23, 2026 Buy	Common shares without par value P-Purchase	Boudreau Philip P EVP And CFO	C-Suite Officer	2 200 Value: $201.3K
Apr 23, 2026 Buy	Common shares without par value I-Discretionary	Boudreau Philip P EVP And CFO	C-Suite Officer	8 909 Value: $820.0K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Ahuja Nita Director	Director	102 Value: $10.5K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	76 Value: $8K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Gonzalez Patricia Paola Director	Director	321 Value: $32.9K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Roman Michael F Director	Director	367 Value: $37.7K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Stratton John G Director	Director	382 Value: $39.2K
Mar 23, 2026 Buy	Common shares without par value	Orville Jacob A Senior Vice President	CEO / President	0 Value: $0
Mar 23, 2026 Buy	Common shares without par value A-Award	Orville Jacob A Senior Vice President	CEO / President	13 255 Value: $1.39M
Mar 02, 2026 Sell	Common shares without par value S-Sale	Cushman Elizabeth C. EVP, GC And Secretary	Officer	263 Value: $30.4K
Mar 02, 2026 Sell	Common shares without par value S-Sale	Shroff Eric Senior Vice President	CEO / President	709 Value: $81.9K
Mar 02, 2026 Sell	Common shares without par value S-Sale	Salvadori Daniel Gesua Sive EVP And Group President	CEO / President	885 Value: $102.3K
Mar 02, 2026 Sell	Common shares without par value S-Sale	Morrone Louis H. Executive Vice President	CEO / President	1 144 Value: $132.2K
Mar 02, 2026 Sell	Common shares without par value S-Sale	Moreland Mary K Executive Vice President	CEO / President	613 Value: $70.9K
Mar 02, 2026 Sell	Common shares without par value S-Sale	Mccoy John A. Jr. Vice President And Controller	CEO / President	585 Value: $67.6K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Boudreau Philip P EVP And CFO	C-Suite Officer	7 441 Value: $865.1K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Cushman Elizabeth C. EVP, GC And Secretary	Officer	1 421 Value: $165.2K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Earnhardt Lisa D EVP And Group President	CEO / President	8 577 Value: $997.2K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Shroff Eric Senior Vice President	CEO / President	1 384 Value: $160.9K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Scoggins Christopher J Executive Vice President	CEO / President	4 997 Value: $581.0K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Salvadori Daniel Gesua Sive EVP And Group President	CEO / President	6 615 Value: $769.1K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Morrone Louis H. Executive Vice President	CEO / President	4 040 Value: $469.7K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Moreland Mary K Executive Vice President	CEO / President	4 630 Value: $538.3K
Feb 27, 2026 Sell	Common shares without par value F-InKind	Mccoy John A. Jr. Vice President And Controller	CEO / President	1 142 Value: $132.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBOTT LABORATORIES

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepa...

Read Full Profile Here